Tricyclic antidepressants updated on 07-01-2025

Cardiac septal defects

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S18161
R76385
Chan (Controls exposed to SSRIs), 2024 Cardiac septal defect 1st trimester retrospective cohort (claims database) exposed to other treatment, sick excluded Adjustment: No Monotherapy: TCA only 1.43 [0.66;3.06] C
excluded (control group)
10/322   21/956 31 322
ref
S18156
R76339
Chan (Controls unexposed, general pop), 2024 Cardiac septal defect 1st trimester retrospective cohort (claims database) unexposed (general population or NOS) excluded Adjustment: Yes Monotherapy: TCA only 3.10 [1.50;6.40]
excluded (control group)
10/322   6,299/462,377 6,309 322
ref
S18157
R76350
Chan (Controls unexposed, sick), 2024 Cardiac septal defect 1st trimester retrospective cohort (claims database) unexposed, sick Adjustment: Yes Monotherapy: TCA only Unexposed sick: old history of illness/treatment (> 12 months before pregnancy) or not specified 0.66 [0.16;2.72] 2/181   74/4,413 76 181
ref
S11052
R40988
Bérard (Controls unexposed, sick), 2017 Ventricular/atrial septal defect 1st trimester retrospective cohort (claims database) unexposed, sick Adjustment: Yes Monotherapy: TCA only Unexposed sick: intermediate history of illness/treatment (3-12 months before pregnancy) 1.10 [0.54;2.24] -/382   -/14,847 - 382
ref
S10938
R40733
Ban (Controls unexposed, disease free), 2014 Septal defects 1st trimester retrospective cohort (claims database) unexposed, disease free Adjustment: Yes Monotherapy: TCA only 0.98 [0.55;1.73] -/2,428   -/325,294 - 2,428
ref
S11668
R42773
Källen, 2013 Septum defects early pregnancy population based cohort retrospective unexposed (general population or NOS) Adjustment: Yes Monotherapy: no or not specified 1.66 [1.17;2.35] 31/2,139   -/- - 2,139
ref
S10930
R40600
Davis, 2007 Bulbus cordis anomalies and anomalies of cardiac septal closure 1st trimester retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: No Monotherapy: no or not specified 0.92 [0.23;3.70] 2/167   680/49,669 682 167
ref
Total 5 studies 1.31 [1.00;1.73] 758 5,297
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Chan (Controls unexposed, sick), 2024Chan, 2024 1 0.66[0.16; 2.72]761814%ROB confusion: seriousROB selection: moderateROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Bérard (Controls unexposed, sick), 2017Bérard, 2017 2 1.10[0.54; 2.24]-38215%ROB confusion: seriousROB selection: moderateROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Ban (Controls unexposed, disease free), 2014Ban, 2014 3 0.98[0.55; 1.73]-2,42822%ROB confusion: seriousROB selection: moderateROB classification: criticalROB missing: lowROB mesure: criticalROB reporting: moderate Källen, 2013Källen, 2013 1.66[1.17; 2.35]-2,13956%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: unclearROB mesure: criticalROB reporting: moderate Davis, 2007Davis, 2007 0.92[0.23; 3.70]6821674%ROB confusion: criticalROB selection: moderateROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Total (5 studies) I2 = 3% 1.31[1.00; 1.73]7585,2970.25.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, sick; 2: Controls unexposed, sick; 3: Controls unexposed, disease free;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.31[1.00; 1.73]7585,2973%NAChan (Controls unexposed, sick), 2024 Bérard (Controls unexposed, sick), 2017 Ban (Controls unexposed, disease free), 2014 Källen, 2013 Davis, 2007 5 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.33[0.90; 1.98]6824,73427%NABan (Controls unexposed, disease free), 2014 Källen, 2013 Davis, 2007 3 unexposed, sickunexposed, sick 0.99[0.53; 1.87]765630%NAChan (Controls unexposed, sick), 2024 Bérard (Controls unexposed, sick), 2017 2 Tags Adjustment   - No  - No 0.92[0.23; 3.69]682167 -NADavis, 2007 1   - Yes  - Yes 1.27[0.91; 1.79]765,13022%NAChan (Controls unexposed, sick), 2024 Bérard (Controls unexposed, sick), 2017 Ban (Controls unexposed, disease free), 2014 Källen, 2013 4 Monotherapy   - no or not specified  - no or not specified 1.60[1.14; 2.25]6822,3060%NAKällen, 2013 Davis, 2007 2   - TCA only  - TCA only 0.99[0.64; 1.51]762,9910%NAChan (Controls unexposed, sick), 2024 Bérard (Controls unexposed, sick), 2017 Ban (Controls unexposed, disease free), 2014 3 Unexposed sick   - intermediate history of illness/tre ...  - intermediate history of illness/treatment (3-12 months before pregnancy) 1.10[0.54; 2.24]-382 -NABérard (Controls unexposed, sick), 2017 1   - old history of illness/treatment (> ...  - old history of illness/treatment (> 12 months before pregnancy) or not specified 0.66[0.16; 2.72]76181 -NAChan (Controls unexposed, sick), 2024 1 All studiesAll studies 1.31[1.00; 1.73]7585,2973%NAChan (Controls unexposed, sick), 2024 Bérard (Controls unexposed, sick), 2017 Ban (Controls unexposed, disease free), 2014 Källen, 2013 Davis, 2007 50.25.01.0

Publication bias and p-hacking diagnosis

funnel plot
0.0-1.72.00.8670.000Chan (Controls unexposed, sick), 2024Bérard (Controls unexposed, sick), 2017Ban (Controls unexposed, disease free), 2014Källen, 2013Davis, 2007

Asymetry test p-value = 0.0792 (by Egger's regression)

slope=0.7110 (0.1853); intercept=-1.6049 (0.6133); t=2.6169; p=0.0792

p values plot
0.01.00.01.0

Sub-groups analysis using all included studies

excluded 18161, 18156

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.56[0.97; 2.51]7,0135,05655%NAChan (Controls unexposed, general pop), 2024 Ban (Controls unexposed, disease free), 2014 Källen, 2013 Davis, 2007 4 unexposed, sick controlsunexposed, sick controls 0.99[0.53; 1.87]765630%NAChan (Controls unexposed, sick), 2024 Bérard (Controls unexposed, sick), 2017 2 exposed to other treatment, sick controlsexposed to other treatment, sick controls 1.43[0.66; 3.06]31322 -NAChan (Controls exposed to SSRIs), 2024 10.510.01.0